Kleinwallstadt, Germany

Herma Glöckner

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2002-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Herma Glockner: Innovator in Membrane Technology

Introduction

Herma Glockner is a notable inventor based in Kleinwallstadt, Germany. She has made significant contributions to the field of membrane technology, particularly in the development of innovative solutions for testing active substances in cells. Her work has implications for various applications in biotechnology and pharmaceuticals.

Latest Patents

Herma Glockner holds a patent for a "Membrane module for testing active substances at cells." This invention features an interior chamber that is defined by a lid, a bottom, and a side wall. The module includes a system of first and second capillary membranes, which are arranged in at least one flat layer parallel to the bottom. The design allows for the formation of a cell culture chamber around the capillary membranes, facilitating the testing of active substances in a controlled environment.

Career Highlights

Herma Glockner is associated with Acordis Industrial Fibers GmbH, where she has been instrumental in advancing membrane technology. Her innovative approach and dedication to research have positioned her as a key figure in her field. With one patent to her name, she continues to explore new avenues for enhancing the functionality of membrane systems.

Collaborations

Herma has collaborated with notable colleagues, including Horst-Dieter Lemke and Friedrich Hauck. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Herma Glockner's contributions to membrane technology exemplify the impact of innovative thinking in scientific research. Her patent for a membrane module represents a significant advancement in the testing of active substances, showcasing her commitment to improving methodologies in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…